Thomas Steyer’s Amedisys AMED Stock Holding History

Thomas Steyer’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-575,000	Closed	-$56.6M	–	147
2025 Q2	$56.6M	Buy	575,000 +50,000	+10%	+$4.73M	0.24%	53
2025 Q1	$48.6M	Sell	525,000 -275,000	-34%	-$25.4M	0.23%	57
2024 Q4	$72.6M	Sell	800,000 -700,000	-47%	-$64.3M	0.32%	54
2024 Q3	$145M	Buy	1,500,000 +191,500	+15%	+$18.7M	0.64%	49
2024 Q2	$120M	Buy	1,308,500 +300,200	+30%	+$27.9M	0.52%	46
2024 Q1	$92.9M	Buy	1,008,300 +322,300	+47%	+$30.2M	0.39%	46
2023 Q4	$65.2M	Buy	686,000 +262,000	+62%	+$24.5M	0.3%	55
2023 Q3	$39.6M	Buy	+424,000	New	+$39.2M	0.18%	66

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Thomas Steyer's AMED Position: Q3 2025 in Review

Thomas Steyer sold out of Amedisys (AMED) in Q3 2025, closing a stake of 575,000 shares — an estimated $56.6M sold.

Thomas Steyer first reported a position in AMED in Q3 2023 and held it in 8 quarters. The position peaked at $145M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Thomas Steyer reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Thomas Steyer sold 575,000 Amedisys shares in Q3 2025, an estimated $56.6M.
Thomas Steyer first reported a position in Amedisys in Q3 2023 and held it in 8 quarters.
Thomas Steyer's Amedisys position peaked at $145M in Q3 2024.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Farallon Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.